Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Modakafusp Alfa for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
Bronx, New York
This trial tests a new drug called modakafusp alfa, given alone or with dexamethasone, for patients whose multiple myeloma has returned or resisted other treatments. The study aims to find the safest and most effective dose while monitoring side effects and benefits. The drug works by specifically targeting cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service